Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results.

Khavinson VKh, Kuznik BI, Ryzhak GA. Adv Gerontol. 2013.

Organ: general-aging · Type: review · Peptides: Thymalin, Thymogen, Vilon, Epithalamin, Prostatilen, Cortexin, Retinalamin

PMID: 24003726

A 2013 Advances in Gerontology review of the authors’ clinical experience with thymic, pineal, prostate, cortex, and retinal peptide bioregulators as geroprotectors — a summary of prior studies, not a new trial.

Editorial summary of a 2013 Advances in Gerontology review (Russian title with English abstract). Public pages cite PubMed only. Read the paper: PMID 24003726.

Methods

Narrative review of long-term clinical work by the authors on peptide bioregulators — Thymalin, Thymogen, Vilon, Epithalamin, Prostatilen, Cortexin, and Retinalamin — for disease prevention and treatment across ages, with emphasis on geroprotective use. No new randomized cohort is generated by this article itself.

Findings

The authors summarize what they take to be clinical efficacy of those preparations and give special attention to their use as geroprotectors. The English abstract does not report new endpoints, sample sizes, or effect sizes.

This is an originating-group clinical overview. It is not independent confirmation of geroprotection. Follow the PMID.